• Citer

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis

par Marta, Guilherme Nader;Martins-Branco, Diogo;Agostinetto, Elisa;Bruzzone, Marco;Ceppi, Marcello;Danielli, L.;Lambertini, Matteo Md Phd M.;Kotecki, Nuria;Awada, Ahmad ;de Azambuja, Evandro
Référence ESMO Open, 7, 3, 100501
Publication Publié, 2022-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis
Auteur:	Marta, Guilherme Nader; Martins-Branco, Diogo; Agostinetto, Elisa; Bruzzone, Marco; Ceppi, Marcello; Danielli, L.; Lambertini, Matteo Md Phd M.; Kotecki, Nuria; Awada, Ahmad; de Azambuja, Evandro
Informations sur la publication:	ESMO Open, 7, 3, 100501
Statut de publication:	Publié, 2022-06
Sujet CREF:	Cancérologie
Mots-clés:	brain metastases
	breast cancer
	HER2
	protein kinase inhibitors
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:2059-7029
	info:doi/10.1016/j.esmoop.2022.100501
	info:pii/S2059702922001211
	info:scp/85132450836
	info:pmid/35653982